Cargando…
Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
The diagnosis of Parkinson’s disease (PD) is challenging at all stages due to variable symptomatology, comorbidities, and mimicking conditions. Postmortem assessment remains the gold standard for a definitive diagnosis. While it is well recognized that PD manifests pathologically in the central nerv...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842941/ https://www.ncbi.nlm.nih.gov/pubmed/35164870 http://dx.doi.org/10.1186/s40478-022-01318-7 |
_version_ | 1784651151230107648 |
---|---|
author | Signaevsky, Maxim Marami, Bahram Prastawa, Marcel Tabish, Nabil Iida, Megan A. Zhang, Xiang Fu Sawyer, Mary Duran, Israel Koenigsberg, Daniel G. Bryce, Clare H. Chahine, Lana M. Mollenhauer, Brit Mosovsky, Sherri Riley, Lindsey Dave, Kuldip D. Eberling, Jamie Coffey, Chris S. Adler, Charles H. Serrano, Geidy E. White, Charles L. Koll, John Fernandez, Gerardo Zeineh, Jack Cordon-Cardo, Carlos Beach, Thomas G. Crary, John F. |
author_facet | Signaevsky, Maxim Marami, Bahram Prastawa, Marcel Tabish, Nabil Iida, Megan A. Zhang, Xiang Fu Sawyer, Mary Duran, Israel Koenigsberg, Daniel G. Bryce, Clare H. Chahine, Lana M. Mollenhauer, Brit Mosovsky, Sherri Riley, Lindsey Dave, Kuldip D. Eberling, Jamie Coffey, Chris S. Adler, Charles H. Serrano, Geidy E. White, Charles L. Koll, John Fernandez, Gerardo Zeineh, Jack Cordon-Cardo, Carlos Beach, Thomas G. Crary, John F. |
author_sort | Signaevsky, Maxim |
collection | PubMed |
description | The diagnosis of Parkinson’s disease (PD) is challenging at all stages due to variable symptomatology, comorbidities, and mimicking conditions. Postmortem assessment remains the gold standard for a definitive diagnosis. While it is well recognized that PD manifests pathologically in the central nervous system with aggregation of α-synuclein as Lewy bodies and neurites, similar Lewy-type synucleinopathy (LTS) is additionally found in the peripheral nervous system that may be useful as an antemortem biomarker. We have previously found that detection of LTS in submandibular gland (SMG) biopsies is sensitive and specific for advanced PD; however, the sensitivity is suboptimal especially for early-stage disease. Further, visual microscopic assessment of biopsies by a neuropathologist to identify LTS is impractical for large-scale adoption. Here, we trained and validated a convolutional neural network (CNN) for detection of LTS on 283 digital whole slide images (WSI) from 95 unique SMG biopsies. A total of 8,450 LTS and 35,066 background objects were annotated following an inter-rater reliability study with Fleiss Kappa = 0.72. We used transfer learning to train a CNN model to classify image patches (151 × 151 pixels at 20× magnification) with and without the presence of LTS objects. The trained CNN model showed the following performance on image patches: sensitivity: 0.99, specificity: 0.99, precision: 0.81, accuracy: 0.99, and F-1 score: 0.89. We further tested the trained network on 1230 naïve WSI from the same cohort of research subjects comprising 42 PD patients and 14 controls. Logistic regression models trained on features engineered from the CNN predictions on the WSI resulted in sensitivity: 0.71, specificity: 0.65, precision: 0.86, accuracy: 0.69, and F-1 score: 0.76 in predicting clinical PD status, and 0.64 accuracy in predicting PD stage, outperforming expert neuropathologist LTS density scoring in terms of sensitivity but not specificity. These findings demonstrate the practical utility of a CNN detector in screening for LTS, which can translate into a computational tool to facilitate the antemortem tissue-based diagnosis of PD in clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01318-7. |
format | Online Article Text |
id | pubmed-8842941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88429412022-02-16 Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence Signaevsky, Maxim Marami, Bahram Prastawa, Marcel Tabish, Nabil Iida, Megan A. Zhang, Xiang Fu Sawyer, Mary Duran, Israel Koenigsberg, Daniel G. Bryce, Clare H. Chahine, Lana M. Mollenhauer, Brit Mosovsky, Sherri Riley, Lindsey Dave, Kuldip D. Eberling, Jamie Coffey, Chris S. Adler, Charles H. Serrano, Geidy E. White, Charles L. Koll, John Fernandez, Gerardo Zeineh, Jack Cordon-Cardo, Carlos Beach, Thomas G. Crary, John F. Acta Neuropathol Commun Research The diagnosis of Parkinson’s disease (PD) is challenging at all stages due to variable symptomatology, comorbidities, and mimicking conditions. Postmortem assessment remains the gold standard for a definitive diagnosis. While it is well recognized that PD manifests pathologically in the central nervous system with aggregation of α-synuclein as Lewy bodies and neurites, similar Lewy-type synucleinopathy (LTS) is additionally found in the peripheral nervous system that may be useful as an antemortem biomarker. We have previously found that detection of LTS in submandibular gland (SMG) biopsies is sensitive and specific for advanced PD; however, the sensitivity is suboptimal especially for early-stage disease. Further, visual microscopic assessment of biopsies by a neuropathologist to identify LTS is impractical for large-scale adoption. Here, we trained and validated a convolutional neural network (CNN) for detection of LTS on 283 digital whole slide images (WSI) from 95 unique SMG biopsies. A total of 8,450 LTS and 35,066 background objects were annotated following an inter-rater reliability study with Fleiss Kappa = 0.72. We used transfer learning to train a CNN model to classify image patches (151 × 151 pixels at 20× magnification) with and without the presence of LTS objects. The trained CNN model showed the following performance on image patches: sensitivity: 0.99, specificity: 0.99, precision: 0.81, accuracy: 0.99, and F-1 score: 0.89. We further tested the trained network on 1230 naïve WSI from the same cohort of research subjects comprising 42 PD patients and 14 controls. Logistic regression models trained on features engineered from the CNN predictions on the WSI resulted in sensitivity: 0.71, specificity: 0.65, precision: 0.86, accuracy: 0.69, and F-1 score: 0.76 in predicting clinical PD status, and 0.64 accuracy in predicting PD stage, outperforming expert neuropathologist LTS density scoring in terms of sensitivity but not specificity. These findings demonstrate the practical utility of a CNN detector in screening for LTS, which can translate into a computational tool to facilitate the antemortem tissue-based diagnosis of PD in clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01318-7. BioMed Central 2022-02-14 /pmc/articles/PMC8842941/ /pubmed/35164870 http://dx.doi.org/10.1186/s40478-022-01318-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Signaevsky, Maxim Marami, Bahram Prastawa, Marcel Tabish, Nabil Iida, Megan A. Zhang, Xiang Fu Sawyer, Mary Duran, Israel Koenigsberg, Daniel G. Bryce, Clare H. Chahine, Lana M. Mollenhauer, Brit Mosovsky, Sherri Riley, Lindsey Dave, Kuldip D. Eberling, Jamie Coffey, Chris S. Adler, Charles H. Serrano, Geidy E. White, Charles L. Koll, John Fernandez, Gerardo Zeineh, Jack Cordon-Cardo, Carlos Beach, Thomas G. Crary, John F. Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence |
title | Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence |
title_full | Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence |
title_fullStr | Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence |
title_full_unstemmed | Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence |
title_short | Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence |
title_sort | antemortem detection of parkinson’s disease pathology in peripheral biopsies using artificial intelligence |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842941/ https://www.ncbi.nlm.nih.gov/pubmed/35164870 http://dx.doi.org/10.1186/s40478-022-01318-7 |
work_keys_str_mv | AT signaevskymaxim antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT maramibahram antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT prastawamarcel antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT tabishnabil antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT iidamegana antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT zhangxiangfu antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT sawyermary antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT duranisrael antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT koenigsbergdanielg antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT bryceclareh antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT chahinelanam antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT mollenhauerbrit antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT mosovskysherri antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT rileylindsey antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT davekuldipd antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT eberlingjamie antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT coffeychriss antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT adlercharlesh antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT serranogeidye antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT whitecharlesl antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT kolljohn antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT fernandezgerardo antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT zeinehjack antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT cordoncardocarlos antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT beachthomasg antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence AT craryjohnf antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence |